Stay updated on Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Sign up to get notified when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.

Latest updates to the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page
- Check7 days agoChange DetectedAdded new MedlinePlus Genetics topic: Multiple myeloma, expanding the page's coverage in health/genetics.SummaryDifference0.1%
- Check14 days agoChange DetectedRemoved a MedlinePlus Genetics topic on multiple myeloma, reducing access to genetic information about this condition. No new content was added.SummaryDifference0.1%
- Check22 days agoChange DetectedTerminology and version update: 'Plasma cell myeloma' is replaced with 'Multiple myeloma', and the revision moves from v3.0.2 to v3.2.0.SummaryDifference0.1%
- Check29 days agoChange DetectedRemoved the MedlinePlus Genetics topic on Multiple myeloma. No new content added to replace it.SummaryDifference0.1%
- Check36 days agoChange DetectedThe page now shows revision v3.0.2; the previous revision v3.0.1 and a 'Back to Top' element were removed. This signals a simple version update with slight navigation adjustments.SummaryDifference0.1%
- Check44 days agoChange DetectedVersion label updated from v3.0.0 to v3.0.1 and a 'Back to Top' link was added; the previous v3.0.0 reference was removed.SummaryDifference0.1%
Stay in the know with updates to Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.